Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Shareholders Equity (Quarterly) : 639.48M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 639.48M |
| June 30, 2026 | 591.73M |
| March 31, 2026 | 593.49M |
| December 31, 2025 | 577.31M |
| Date | Value |
|---|---|
| September 30, 2025 | 478.36M |
| June 30, 2025 | 452.90M |
| March 31, 2025 | -353.75M |
| December 31, 2024 | -277.19M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Natera, Inc. | 1.870B |
| Myriad Genetics, Inc. | 269.00M |
| BioRestorative Therapies, Inc. | 3.026M |
| CareDx, Inc. | 467.46M |
| Exagen, Inc. | 13.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.256B |
| Total Liabilities (Quarterly) | 616.14M |
| Debt to Equity Ratio | 0.7241 |
| Current Ratio | 6.715 |
| Net Debt Paydown Yield | -0.10% |